An analysis by Vanguard Communications suggests more weight is attached to physician patient reviews compared to those of hotels and restaurants.
What influences patients the most when choosing a surgeon for a facelift procedure? Dr. Adam Honeybrook reveals the surprising social media research results his team uncovered.
The distribution agreement between Revance and Swiss HA-based dermal filler and cosmeceutical manufacturing company, TEOXANE SA, may position Revance as a leader in the U.S. facial injectable market.
Prebiotics, probiotics, postbiotics and peptides — according to Dr. Manjula Jegasothy, all eyes should be on these.
From plasma energy to CBD in skincare, these are a few of the hot topics the Dermatology Times team covered in 2019 that are worthy of keeping an eye on in 2020.
Dr. Joel Schlessinger prides himself on creating an interactive and open discussion opportunity at Cosmetic Surgery Forum, and he says his reasoning is simple: Why speculate when the experts are in the room?
Dr. Randolph Waldman wants his colleagues to know how important it is to be aware of rare complications that can unexpectedly arise, such as acute glaucoma post blepharoplasty.
Medical aesthetic company Cynosure announces TempSure Firm, a new RF treatment for stubborn cellulite.
Study shows clinical benefit of PRP in a stabilized vehicle for SoME Skincare product.
As non-surgical aesthetic procedures continue to grow, so do the number of medical spas that perform cosmetic treatments. According to Dr. Renato Saltz, that’s not necessarily a bad thing.